Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Jing-ting Yu
ResearcherPublications, citations & collaboration network
Jing-ting Yu is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 3 works, 0 citations, an h-index of 0 and an i10-index of 0.
3
Works
0
Citations
0
h-index
0
i10-index
IDs:OpenAlex
How has Jing-ting Yu's publication output changed over time?
ScholarIQpublication output · 2023–2026
Output grew0% over the shown period — from 1 works in 2023 to 1 in 2026.
1
1
1
202320242026
What are the most-cited papers on Jing-ting Yu?
ScholarIQmost cited works
Aspirin intervention before ICU admission reduced the mortality in critically ill patients with acute kidney injury: Results From the MIMIC-IV
Yao Meng, Yi Lin, Jiawei Zhang, Wenli Zou, Yueming Liu, Xiaogang Shen, Quan-quan Shen, Minmin Wang, Lina Shao, H.-P. Feng, Yan Zhu, Jing-ting Yu, Bo Lin, Bin Zhu
Research Square. 20230 CitationsOPEN ACCESS
Global glomerulosclerosis proportions above 10% predict nephropathy progression in IgA Nephropathy: a multicenter retrospective analysis with propensity score matching
Wenli Zou, Yueming Liu, Baihui Xu, Juan Wu, Wei Shen, Wei Zhang, Jiawei Zhang, Yao Meng, Yan Zhu, Jing-ting Yu, Jian-guang Gong, Xiaogang Shen, Bin Zhu
Research Square. 20240 CitationsOPEN ACCESS
Finerenone in IgA nephropathy: real-world 12-month propensity-matched cohort demonstrating proteinuria reduction, eGFR preservation, and safety profile
Wei Zhang, Jing-ting Yu, Bo Lin, Xiaogang Shen, Maosheng Chen, Yidong Zhou, Yu-jia Zhang, Cheng-cong Zhuo, Zhi-liang Jiang, Bin Zhu
Renal Failure. 20260 CitationsOPEN ACCESS
Related on ScholarIQ
Zhejiang Chinese Medical University
Institution
Aspirin intervention before ICU admission reduced the mortality in critically ill patients with acute kidney injury: Results From the MIMIC-IV
Paper
Global glomerulosclerosis proportions above 10% predict nephropathy progression in IgA Nephropathy: a multicenter retrospective analysis with propensity score matching
Paper
Finerenone in IgA nephropathy: real-world 12-month propensity-matched cohort demonstrating proteinuria reduction, eGFR preservation, and safety profile
Paper
Chronic Kidney Disease and Diabetes
Topic
Renal Diseases and Glomerulopathies
Topic